Hexokinase 2 (HK2) was further identified as the downstream target of piRNA-30473-WTAP-m6A, and upregulated HK2 by piRNA-30473 contributed to DLBCL tumorigenesis (Han et al., 2021). The gene discussed is HK2; the disease is diffuse large B-cell lymphoma.